ISAEC Launches New Study in IBD; Completes Enrollment in Hypersensitivity, Liver Toxicity Trials | GenomeWeb

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium has finished enrolling two studies investigating genetic markers linked to drug-induced liver injury and hypersensitivity reactions, and it has launched a new study focused on finding markers of treatment-related inflammatory bowel disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.